pillbase.ru

Genvoya

Active substance: ELVITEGRAVIR, COBICISTAT, EMTRICITABINE, TENOFOVIR ALAFENAMIDE FUMARATE

TABLET · ELVITEGRAVIR 150 mg/1, COBICISTAT 150 mg/1, EMTRICITABINE 200 mg/1, TENOFOVIR ALAFENAMIDE FUMARATE 10 mg/1

United StatesActive

Marketing holder: Gilead Sciences, Inc.

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Products containing elvitegravir in other countries

Showing products with this active substance, combinations included; the full composition is shown for each product.

CountryProducts
RU 2
  • Генвоя®
    таблетки, покрытые пленочной оболочкой, 150 мг+10 мг+150 мг+200 мг (original in Russian, GRLS)
    ЛП-№(005222)-(РГ-RU)
    Гилеад Сайенсиз Интернешнл Лимитед
  • Генвоя®
    таблетки, покрытые пленочной оболочкой, 150 мг+10 мг+150 мг+200 мг (original in Russian, GRLS)
    ЛП-005722
    Гилеад Сайенсиз Интернешнл Лимитед
EU 3
  • Genvoya
    elvitegravir, cobicistat, emtricitabine, tenofovir alafenamide
    EMEA/H/C/004042
    Gilead Sciences Ireland UC
  • Stribild
    elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate
    EMEA/H/C/002574
    Gilead Sciences Ireland UC
  • Vitekta
    elvitegravir
    EMEA/H/C/002577
    Gilead Sciences International Ltd
Registration
Registration number
61958-1901
Registration status
Active
Dispensing
Prescription only
Route
ORAL
Sources
  • product · openFDA NDC · 61958-1901 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 61958-1901 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 61958-1901 · Verified 2026-10-09 · open in source
  • ingredients.1 · openFDA NDC · 61958-1901 · Verified 2026-10-09 · open in source
  • ingredients.2 · openFDA NDC · 61958-1901 · Verified 2026-10-09 · open in source
  • ingredients.3 · openFDA NDC · 61958-1901 · Verified 2026-10-09 · open in source